Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Shares Issued (2021 - 2025)

Zymeworks' Shares Issued history spans 3 years, with the latest figure at $22.0 million for Q4 2023.

  • For Q4 2023, Shares Issued rose 15725.18% year-over-year to $22.0 million; the TTM value through Dec 2023 reached $26.2 million, up 10187.45%, while the annual FY2025 figure was $5.0 million, N/A changed from the prior year.
  • Shares Issued for Q4 2023 was $22.0 million at Zymeworks, up from $1.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $107.5 million in Q2 2022 and bottomed at -$107.4 million in Q3 2022.
  • The 3-year median for Shares Issued is $1.3 million (2023), against an average of $2.3 million.
  • The largest YoY upside for Shares Issued was 15725.18% in 2023 against a maximum downside of 98.71% in 2023.
  • A 3-year view of Shares Issued shows it stood at -$5.4 million in 2021, then surged by 102.56% to $139000.0 in 2022, then skyrocketed by 15725.18% to $22.0 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Shares Issued are $22.0 million (Q4 2023), $1.3 million (Q3 2023), and $1.4 million (Q2 2023).